
Invicta Diagnostic (INVICTA) Share Price Falls 10.12% to Rs 74.60: Price Action, Fundamentals and Sector View
Updated: 16 Nov 2026 • 12:56 pm
Posted by:

Invicta Diagnostic Share Price fell 10.12% on 16 November 2026, with the stock last trading at Rs 74.60 against a previous close of Rs 83.00 as of 16 November 2026 at 12:53:04 PM IST. The decline of Rs 8.40 leaves Invicta Diagnostic, a Micro Cap company in the Hospital & Healthcare Services industry, with a market capitalisation of Rs 104.35 crore.
The stock opened at Rs 78.20, below its previous close, touched a high of Rs 78.25 and has since slid to a low of Rs 74.60, which is also its current price. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. The Invicta Diagnostic share price news today is therefore about the size of the move and the verified numbers behind it.
The key metrics are a P/E ratio of 21.27, a P/B ratio of 2.06, ROE of 14.93% and ROCE of 19.88%. Next, investors can monitor whether the Invicta Diagnostic stock holds above the day's low, how its fundamentals compare with the Hospital & Healthcare Services benchmark, and any company announcement that follows.
Invicta Diagnostic (INVICTA) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 74.6 |
| Previous Close | Rs 83 |
| Today's Move | -Rs 8.40 (-10.12%) |
| Open | Rs 78.2 |
| High | Rs 78.25 |
| Low | Rs 74.6 |
| Market Capitalisation | Rs 104.35 crore |
| Market Cap Category | Micro Cap |
Invicta Diagnostic share price today is Rs 74.60, down Rs 8.40 or 10.12% from the previous close of Rs 83.00. The session began with a gap lower, as trading opened at Rs 78.20, which is Rs 4.80 below the previous close, and the stock has kept falling since.
The day's range runs from Rs 74.60 to Rs 78.25, a spread of Rs 3.65. The intraday high of Rs 78.25 is only Rs 0.05 above the opening price, so buyers had little room above the open before the decline resumed. The price is now Rs 3.60 below the opening level.
As of 12:53 PM IST, the stock sits exactly at the day's low of Rs 74.60 and Rs 3.65 below the day's high. This is where the Invicta Diagnostic share price update places the stock inside its range, and it is the level to compare against as the session continues.
Invicta Diagnostic is classified as a Micro Cap company, and its market capitalisation stands at Rs 104.35 crore. Market capitalisation indicates company size, not quality, so it frames the scale of the business rather than the reason for the Invicta Diagnostic share price fall seen today. The price action is clear, and the next step is to read the fundamentals behind it.
Invicta Diagnostic (INVICTA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 104.35 crore |
| P/E Ratio | 21.27x |
| P/B Ratio | 2.06x |
| ROE | 14.93% |
| ROCE | 19.88% |
| EPS | Rs 3.9 |
| Book Value Per Share | Rs 40.3 |
| Dividend Yield | 0% |
Invicta Diagnostic (INVICTA) fundamental metrics show P/E 21.27x, P/B 2.06x, ROE 14.93%, ROCE 19.88%. These figures provide context only and are not a buy or sell signal.
Invicta Diagnostic has a market capitalisation of Rs 104.35 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 21.27x, P/B at 2.06x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 14.93% and ROCE of 19.88%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 3.9, book value per share of Rs 40.3, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 44.34x, median ROE of 12.88%, median ROCE of 15.43%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Hospital & Healthcare Services |
| Benchmark Scope | same industry |
| Company P/E Ratio | 21.27x |
| Benchmark Median P/E | 44.34x |
| Benchmark Average P/E | 74.75x |
| Benchmark P/E Range | 6.09x to 755.5x |
| Company P/B Ratio | 2.06x |
| Benchmark Median P/B | 3.62x |
| Benchmark Average P/B | 4.03x |
| Company ROE | 14.93% |
| Benchmark Median ROE | 12.88% |
| Benchmark Average ROE | 10.02% |
| Company ROCE | 19.88% |
| Benchmark Median ROCE | 15.43% |
| Benchmark Average ROCE | 1.55% |
| Company Market Capitalisation | Rs 104.35 crore |
| Benchmark Median Market Cap | Rs 583.5 crore |
| Benchmark Average Market Cap | Rs 10,761.21 crore |
Invicta Diagnostic (INVICTA) operates in the Healthcare sector, within the Hospital & Healthcare Services industry.
Invicta Diagnostic (INVICTA) has a P/E ratio of 21.27x, which is below the benchmark median of 44.34x, a difference of -52.03%. On its own, the P/E gap is a valuation reference point, not a trading call.
Invicta Diagnostic (INVICTA) has a ROE of 14.93%, which is above the benchmark median of 12.88%, a difference of +15.92%. Invicta Diagnostic (INVICTA) has a ROCE of 19.88%, which is above the benchmark median of 15.43%, a difference of +28.84%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise | APOLLOHOSP | 1,22,439.82 | 54.61 | 11.55 | 23.54 | 21.73 |
| Max Healthcare Institute | MAXHEALTH | 91,979.41 | 66.62 | 8.12 | 14.53 | 14.97 |
| MANIPAL HEALTH ENTERPRI L | MANIPALHOS | 89,445.65 | 100.24 | 5.35 | 12.95 | 13.93 |
| Aster DM Healthcare | ASTERDM | 62,952.18 | 133.74 | 8.46 | 13.07 | 16.22 |
| Fortis Healthcare | FORTIS | 57,754.3 | 55.62 | 5.51 | 11.32 | 14.07 |
Invicta Diagnostic (INVICTA) has a P/E ratio of 21.27x compared with the displayed peer median of 66.62x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 14.93% compares with a peer median of 13.07% across the companies shown in the table. ROCE stood at 19.88% versus the displayed peer median of 14.97%, providing a capital-efficiency comparison. Invicta Diagnostic (INVICTA) has a market capitalisation of Rs 104.35 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Invicta Diagnostic
- Price action: the stock opened Rs 4.80 below its previous close and fell a total of Rs 8.40 per share, trading at the day's low of Rs 74.60.
- Valuation: the P/E ratio of 21.27 and P/B ratio of 2.06 are both below the Hospital & Healthcare Services benchmark medians.
- Returns: ROE of 14.93% and ROCE of 19.88% are both above the benchmark medians.
- Size: a Micro Cap market capitalisation of Rs 104.35 crore, below the sector median of Rs 583.50 crore.
- Per-share data: EPS of Rs 3.90, book value of Rs 40.30 and a dividend yield of 0%.
About Invicta Diagnostic
Invicta Diagnostic is a listed company in the Healthcare sector and the Hospital & Healthcare Services industry, and it is classified as a Micro Cap. It is one of 67 companies in the same-industry benchmark, where its market capitalisation of Rs 104.35 crore is below the median of Rs 583.50 crore.
Hospital & Healthcare Services is the group against which its P/E, P/B, ROE and ROCE are measured, and Apollo Hospitals Enterprise, Max Healthcare Institute and Manipal Health Enterprises are among the larger listed names in it. This sector context frames the company's financial ratios and the Invicta Diagnostic stock performance today.
Track Invicta Diagnostic Share Price on Univest
Use Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Readers can follow the live Invicta Diagnostic share price on Univest, along with fundamental ratios such as the P/E ratio, P/B ratio, ROE and ROCE, 52-week levels and wider market insights. Univest also lets users compare Invicta Diagnostic with sector peers and review the Healthcare group in one place, so the share price and the numbers behind it stay together.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Invicta Diagnostic share price falling today?
Ans. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. The Invicta Diagnostic share price fell 10.12% to Rs 74.60 from a previous close of Rs 83.00.
What is the Invicta Diagnostic share price today?
Ans. As of 12:53 PM IST, the Invicta Diagnostic share price is Rs 74.60, down Rs 8.40 from the previous close of Rs 83.00, with a day high of Rs 78.25 and a day low of Rs 74.60.
What is the market capitalisation of Invicta Diagnostic?
Ans. The Invicta Diagnostic share price reflects a market capitalisation of Rs 104.35 crore, a Micro Cap. That is below the sector benchmark median of Rs 583.50 crore and the average of Rs 10,761.21 crore.
What is the P/E ratio of Invicta Diagnostic?
Ans. At a P/E ratio of 21.27, the Invicta Diagnostic share price is valued below the sector benchmark median of 44.34 and the average of 74.75, based on 58 companies with a reported P/E ratio.
What are the ROE and ROCE of Invicta Diagnostic?
Ans. Invicta Diagnostic reports ROE of 14.93% and ROCE of 19.88%. The sector benchmark median is 12.88% for ROE and 15.43% for ROCE, so both company figures are above the sector median.
What are the EPS and book value of Invicta Diagnostic?
Ans. Invicta Diagnostic reports EPS of Rs 3.90 and a book value of Rs 40.30 per share. With a P/B ratio of 2.06, the Invicta Diagnostic share price of Rs 74.60 sits above book value per share.
Does Invicta Diagnostic pay a dividend?
Ans. The dividend yield for Invicta Diagnostic is 0%. Dividend yield is historical and current data, not a promise of future payouts, and it is measured against the Invicta Diagnostic share price of Rs 74.60.
How does Invicta Diagnostic compare with its peers?
Ans. Its P/E ratio of 21.27 and P/B ratio of 2.06 are below all five peers. Its ROE of 14.93% is above four of them and below only Apollo Hospitals Enterprise at 23.54%.
What should investors monitor in Invicta Diagnostic stock news?
Ans. Investors can monitor company announcements, whether the price holds above the day's low of Rs 74.60 and how it trades against the previous close of Rs 83.00, and how the P/E and P/B ratios compare with the sector benchmark.
Recent Articles

S&S Power Switchgear (S&SPOWER) Share Price Falls 10% to Rs 306.00: Price Action, Fundamentals and Sector View
16 November 2026

Flomic Global Logistics (FLOMIC) Share Price Rise: Stock Gains 8.38% Today
16 November 2026

RDB Rasayans (RDBRL) Share Price Falls 9.49% to Rs 127.85: Price Action, Fundamentals and Sector View
16 November 2026

Transworld Shipping Lines (TRANSWORLD) Share Price Falls 10% to Rs 205.30 Today
16 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
S&S Power Switchgear (S&SPOWER) Share Price Falls 10% to Rs 306.00: Price Action, Fundamentals and Sector View
Flomic Global Logistics (FLOMIC) Share Price Rise: Stock Gains 8.38% Today
RDB Rasayans (RDBRL) Share Price Falls 9.49% to Rs 127.85: Price Action, Fundamentals and Sector View
Transworld Shipping Lines (TRANSWORLD) Share Price Falls 10% to Rs 205.30 Today
Commercial Syn Bags (COMSYN) Share Price Rise: Stock Gains 8.91% Today
Popular this week
Zomato (ETERNAL) Share Price Touches Fresh 52-Week High of Rs 372.45

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





